ReviewHematology, transfusion and cell therapy

Targeted therapy with a selective BCL-2 inhibitor in older patients with acute myeloid leukemia.

Elisabete do Vale Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.